Certain variations in the gene that codes for the inflammatory signaling molecule TGF-beta1 are associated with faster lung function decline…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
There is wide clinical variety in the presentation of individuals who carry one F508del mutation and one 5T;TG12 mutation in…
Infants with cystic fibrosis (CF) who are infected with Pseudomonas aeruginosa in their first six months are at heightened…
Scientists at the University of Southampton have created a new method that could be useful for rapidly identifying infectious bacteria…
A natural compound called ectoine may help to improve the stability of the CFTR protein by modulating the activity…
Health Canada has expanded the approval of Vertex Pharmaceuticals‘ triple-combination modulator treatment Trikafta to cover children with cystic fibrosis…
Sionna Therapeutics, a life sciences company that is developing a pipeline of experimental treatments for cystic fibrosis (CF), has…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
As part of its Path to a Cure initiative, the Cystic Fibrosis Foundation is readying its first “Golden Ticket” Competition,…
The first participant has been enrolled in a Phase 1 clinical trial testing the safety and pharmacological properties of the…